[go: up one dir, main page]

DK2839013T3 - Ikke-disruptiv-gen-targetering - Google Patents

Ikke-disruptiv-gen-targetering Download PDF

Info

Publication number
DK2839013T3
DK2839013T3 DK13778431.0T DK13778431T DK2839013T3 DK 2839013 T3 DK2839013 T3 DK 2839013T3 DK 13778431 T DK13778431 T DK 13778431T DK 2839013 T3 DK2839013 T3 DK 2839013T3
Authority
DK
Denmark
Prior art keywords
disruptive
gen
targeting
Prior art date
Application number
DK13778431.0T
Other languages
English (en)
Inventor
Matthew Porteus
Josh Checketts
Adi Barzel
Mark A Kay
Richard Voit
Jenny Barker
Original Assignee
Univ Leland Stanford Junior
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior, Univ Texas filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of DK2839013T3 publication Critical patent/DK2839013T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • C12N15/902Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/12Animals modified by administration of exogenous cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/80Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/80Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK13778431.0T 2012-04-18 2013-03-15 Ikke-disruptiv-gen-targetering DK2839013T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261635203P 2012-04-18 2012-04-18
US201261654645P 2012-06-01 2012-06-01
PCT/US2013/032443 WO2013158309A2 (en) 2012-04-18 2013-03-15 Non-disruptive gene targeting

Publications (1)

Publication Number Publication Date
DK2839013T3 true DK2839013T3 (da) 2020-09-14

Family

ID=49380320

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13778431.0T DK2839013T3 (da) 2012-04-18 2013-03-15 Ikke-disruptiv-gen-targetering

Country Status (5)

Country Link
US (4) US20130280222A1 (da)
EP (2) EP2839013B1 (da)
DK (1) DK2839013T3 (da)
ES (1) ES2828663T3 (da)
WO (1) WO2013158309A2 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2854866A4 (en) * 2012-05-30 2015-12-23 Baylor College Medicine SUPERHELIC MINI-SECTORS AS A TOOL FOR DNS REPAIR, CHANGE AND REPLACEMENT
US10648001B2 (en) 2012-07-11 2020-05-12 Sangamo Therapeutics, Inc. Method of treating mucopolysaccharidosis type I or II
AU2013289206B2 (en) 2012-07-11 2018-08-09 Sangamo Therapeutics, Inc. Methods and compositions for the treatment of lysosomal storage diseases
WO2015068785A1 (ja) * 2013-11-06 2015-05-14 国立大学法人広島大学 核酸挿入用ベクター
EP3119895B1 (en) 2014-03-21 2023-12-20 The Board of Trustees of the Leland Stanford Junior University Genome editing without nucleases
US20170051354A1 (en) * 2014-04-28 2017-02-23 Sigma-Aldrich Co. Llc Epigenetic modification of mammalian genomes using targeted endonucleases
US10351825B2 (en) * 2014-07-11 2019-07-16 The Texas A&M University System Mesenchymal stem cells derived from induced pluripotent stem cells
JP2017534301A (ja) * 2014-11-10 2017-11-24 マードック チルドレンズ リサーチ インスティチュート 構成的に発現された遺伝子を含む遺伝子座における標的を狙った組み込みのためのベクター及び方法
US20170369848A1 (en) * 2014-11-11 2017-12-28 Q Therapeutics, Inc. Engineering mesenchymal stem cells using homologous recombination
US20170362580A1 (en) * 2014-12-12 2017-12-21 James Zhu Methods and compositions for selectively eliminating cells of interest
EP3250680A4 (en) 2015-01-26 2018-12-05 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
MY187898A (en) 2015-03-02 2021-10-27 Adverum Biotechnologies Inc Compositions and methods for intravitreal delivery of polynucleotides to retinal cones
EP3294866A4 (en) * 2015-05-12 2018-12-05 Sangamo Therapeutics, Inc. Nuclease-mediated regulation of gene expression
WO2017053729A1 (en) * 2015-09-25 2017-03-30 The Board Of Trustees Of The Leland Stanford Junior University Nuclease-mediated genome editing of primary cells and enrichment thereof
EP3371314B1 (en) 2015-11-04 2023-07-05 Fate Therapeutics, Inc. Genomic engineering of pluripotent cells
AU2016348342B2 (en) 2015-11-04 2023-07-06 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
WO2017091512A1 (en) * 2015-11-23 2017-06-01 Sangamo Biosciences, Inc. Methods and compositions for engineering immunity
EP3443085B1 (en) * 2016-04-14 2022-09-14 BOCO Silicon Valley, Inc. Genome editing of human neural stem cells using nucleases
PT4180519T (pt) 2016-04-15 2025-09-04 Memorial Sloan Kettering Cancer Center Células t transgénicas e composições de células t que expressam um recetor antigénico quimérico e métodos relacionados
TW201839136A (zh) 2017-02-06 2018-11-01 瑞士商諾華公司 治療血色素異常症之組合物及方法
EP3682004A4 (en) * 2017-09-15 2021-05-26 The Board of Trustees of the Leland Stanford Junior University MULTIPLEX PRODUCTION AND BARCODING OF GENETICALLY MODIFIED CELLS
BR112020015798A2 (pt) 2018-02-01 2021-03-09 Homology Medicines, Inc. Composições de vírus adeno-associado para restaurar função de gene da pah e métodos de uso das mesmas
CA3092832A1 (en) * 2018-03-02 2019-09-06 Generation Bio Co. Identifying and characterizing genomic safe harbors (gsh) in humans and murine genomes, and viral and non-viral vector compositions for targeted integration at an identified gsh loci
AU2018436152A1 (en) 2018-08-10 2021-02-04 Logicbio Therapeutics, Inc. Non-disruptive gene therapy for the treatment of MMA
CN113166754A (zh) 2018-10-16 2021-07-23 蓝色等位基因有限责任公司 用于将dna靶向插入基因中的方法
JP7578590B2 (ja) 2018-10-18 2024-11-06 インテリア セラピューティクス,インコーポレーテッド 第ix因子を発現するための組成物及び方法
CN113166769A (zh) * 2018-11-01 2021-07-23 蓝色等位基因有限责任公司 用于改变遗传病症的基因表达的方法
LU101118B1 (en) 2019-02-06 2020-08-06 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Method for detecting a specific splice event of a gene of interest
AU2020279370A1 (en) * 2019-05-21 2021-12-16 Sangamo Therapeutics, Inc. Controlled transgene expression in regulatory T cells
US11622547B2 (en) 2019-06-07 2023-04-11 Regeneran Pharmaceuticals, Inc. Genetically modified mouse that expresses human albumin
CA3154998A1 (en) * 2019-09-17 2021-03-25 Memorial Sloan-Kettering Cancer Center Methods for identifying genomic safe harbors
MX2022005572A (es) 2019-11-08 2022-06-09 Regeneron Pharma Estrategias crispr y aav para la terapia de retinosquisis juvenil ligada al cromosoma x.
IL297881A (en) * 2020-05-04 2023-01-01 Editas Medicine Inc Selection by essential-gene knock-in
TW202208632A (zh) 2020-05-27 2022-03-01 美商同源醫藥公司 用於恢復pah基因功能的腺相關病毒組成物及其使用方法
WO2022008510A2 (en) 2020-07-06 2022-01-13 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Intron-encoded extranuclear transcripts for protein translation, rna encoding, and multi-timepoint interrogation of non-coding or protein-coding rna regulation
EP4323515A4 (en) * 2021-04-15 2025-03-12 Altius Institute For Biomedical Sciences Dna binding proteins for regulating gene expression
CA3235446A1 (en) 2021-10-14 2023-04-20 Asimov Inc. Integrases, landing pad architectures, and engineered cells comprising the same
JP2024543373A (ja) 2021-11-09 2024-11-21 アシモフ,インコーポレーテッド Aavベクター産生のための安定な産生系
CA3256767A1 (en) 2022-05-23 2023-11-30 Logicbio Therapeutics, Inc. Gene therapy compositions and their methods of use
WO2024064744A2 (en) * 2022-09-20 2024-03-28 Dna Twopointo, Inc. Engineered split dhfr-based methods and systems for selecting cells that have stably acquired a heterologous polynucleotide
WO2024223931A1 (en) 2023-04-28 2024-10-31 AstraZeneca Ireland Limited Manufacturing and use of recombinant self-complementary aav vectors

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006667A1 (en) * 1989-11-06 1991-05-16 Cell Genesys, Inc. Production of proteins using homologous recombination
US5222982A (en) 1991-02-11 1993-06-29 Ommaya Ayub K Spinal fluid driven artificial organ
JPH06505186A (ja) 1991-02-11 1994-06-16 オマーヤ,アユブ ケー. 脊髄液駆動式人工器官
ATE262912T1 (de) * 1993-01-29 2004-04-15 Neurospheres Holdings Ltd Genetische modifikation von neuralen stammzellen
JP4375759B2 (ja) * 1993-04-21 2009-12-02 ザ・ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・エディンバラ 標的とされた発現特性に従う異種遺伝子の発現
US20040208846A1 (en) * 1996-05-31 2004-10-21 Wei-Wei Zhang Mini-Ad vector for immunization
GB9710809D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
GB9710807D0 (en) 1997-05-23 1997-07-23 Medical Res Council Nucleic acid binding proteins
NZ504511A (en) 1997-11-18 2002-12-20 Pioneer Hi Bred Int Recombinant proteins comprising fused first and second distinct site specific recombinase and use in methods for the integration of foreign DNA into eukaryotic genomes
US5929301A (en) 1997-11-18 1999-07-27 Pioneer Hi-Bred International Nucleic acid sequence encoding FLP recombinase
US6140081A (en) 1998-10-16 2000-10-31 The Scripps Research Institute Zinc finger binding domains for GNN
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
JP2002060786A (ja) 2000-08-23 2002-02-26 Kao Corp 硬質表面用殺菌防汚剤
AT5356U1 (de) 2001-07-16 2002-06-25 Uv & P Umweltman Verfahrenstec Verfahren zur immobilisierung von verbrennungsrückständen
AUPR666501A0 (en) * 2001-07-27 2001-08-23 Murdoch Childrens Research Institute, The A method for selection and agents useful for same
AU2002336373A1 (en) 2001-08-20 2003-03-03 The Scripps Research Institute Zinc finger binding domains for cnn
US7888121B2 (en) 2003-08-08 2011-02-15 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
US7972854B2 (en) 2004-02-05 2011-07-05 Sangamo Biosciences, Inc. Methods and compositions for targeted cleavage and recombination
CA2615532C (en) * 2005-07-26 2016-06-28 Sangamo Biosciences, Inc. Targeted integration and expression of exogenous nucleic acid sequences
SI2019683T2 (sl) 2006-04-25 2022-10-28 The Regents Of The University Of California Dajanje rastnih faktorjev za zdravljenje motenj CŽS
WO2008060360A2 (en) 2006-09-28 2008-05-22 Surmodics, Inc. Implantable medical device with apertures for delivery of bioactive agents
US8110379B2 (en) * 2007-04-26 2012-02-07 Sangamo Biosciences, Inc. Targeted integration into the PPP1R12C locus
US8521273B2 (en) 2008-01-29 2013-08-27 Gilbert H. KLIMAN Drug delivery devices, kits and methods therefor
US9314005B2 (en) * 2009-07-01 2016-04-19 Transposagen Biopharmaceuticals, Inc. Genetically modified rat models for severe combined immunodeficiency (SCID)
DK2462230T3 (da) * 2009-08-03 2015-10-19 Recombinetics Inc Fremgangsmåder og sammensætninger til målrettet genmodifikation
DK2816112T3 (da) 2009-12-10 2018-11-19 Univ Minnesota TAL-effektor-medieret DNA-modifikation
EP2660318A1 (en) * 2010-02-09 2013-11-06 Sangamo BioSciences, Inc. Targeted genomic modification with partially single-stranded donor molecules
WO2011130343A1 (en) * 2010-04-13 2011-10-20 Sigma-Aldrich Co. Biosensors comprising protein-binding domains and fluorescent proteins
US20140127814A1 (en) * 2010-08-10 2014-05-08 Srinivasan Chandrasegaran Generation and use of pluripotent stem cells
EP2694089B1 (en) * 2011-04-05 2024-06-05 Cellectis New tale-protein scaffolds and uses thereof

Also Published As

Publication number Publication date
EP2839013A4 (en) 2016-05-11
EP3839050A3 (en) 2021-09-29
US20130280222A1 (en) 2013-10-24
WO2013158309A2 (en) 2013-10-24
EP2839013A2 (en) 2015-02-25
US20170233765A1 (en) 2017-08-17
US20220204995A1 (en) 2022-06-30
WO2013158309A3 (en) 2014-01-03
US20210214752A1 (en) 2021-07-15
ES2828663T3 (es) 2021-05-27
EP2839013B1 (en) 2020-08-26
EP3839050A2 (en) 2021-06-23

Similar Documents

Publication Publication Date Title
EP2763896A4 (en) UNMANUFACTURED AIRCRAFT WITH SEVERAL ROTORS
DK2859055T3 (da) Polymercoatings
EP2880683A4 (en) BVA INTERPOSER
DK2825087T3 (da) Otoscanner
EP2809145A4 (en) CHLOROPLAST TRANSIT PEPTIDES
DK2839013T3 (da) Ikke-disruptiv-gen-targetering
EP2824794A4 (en) Charging cable
EP2847405A4 (en) DOOR CLOSURE SYSTEM
EP2805877A4 (en) UNDER HOOD
DK2873977T3 (da) Dobbeltdækker-rørdispenser
DE112012006109A5 (de) Okklusionsschienenanordnung
DK2854722T3 (da) Stomipose
EP2941099A4 (en) SWITCHING DEVICE
EP2831482A4 (en) Flange gasket
EP2816694A4 (en) FLAT CABLE WINDING DEVICE
DK2825157T3 (da) Aminosyrelipider
EP2809729A4 (en) Siloxane polyether copolymers
EP2862179A4 (en) FUEL CURRENT INSPECTION PROBE
EP2869113A4 (en) DISPLAY DEVICE FOR VEHICLE
DE112012006214T8 (de) Wulstringwickler
DK2831122T3 (da) Anthocyanidin-kompleks
DK2885638T3 (da) Molekylenet
DE112012005566T8 (de) Seltenerdnanoverbundmagnet
EP2873363A4 (en) DIOPSIMETER
DK2858657T3 (da) Feijoafrugtekstrakt